SEC Form 4 · accession 0001209191-17-050096
AGIOS PHARMACEUTICALS, INC. · AGIO
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Lewis Clayton Cantley Jr.
Director
Period of report
Aug 22, 2017
Accepted (ET)
Aug 24, 2017 · 4:13 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001439222
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common stockF2,F3 | Aug 22, 2017 | S | 500 | $56.63 | D | 88,894 | D | |
| Common stockF2,F4,F5 | Aug 22, 2017 | S | 500 | $56.63 | D | 88,934 | I | See footnote |
| Common stockF6 | Aug 22, 2017 | S | 500 | $56.61 | D | 88,394 | D | |
| Common stockF6,F5 | Aug 22, 2017 | S | 500 | $56.61 | D | 88,434 | I | See footnote |
| Common stockF7 | Aug 23, 2017 | S | 500 | $57.09 | D | 87,894 | D | |
| Common stockF7,F5 | Aug 23, 2017 | S | 500 | $57.09 | D | 87,934 | I | See footnote |
| Common stockF8 | Aug 23, 2017 | S | 500 | $57.07 | D | 87,394 | D | |
| Common stockF8,F5 | Aug 23, 2017 | S | 500 | $57.07 | D | 87,434 | I | See footnote |
| Common stockF3,F9 | holding | — | — | — | 20,803 | I | See footnote | |
| Common stockF4,F10 | holding | — | — | — | 20,803 | I | See footnote |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
- F10Shares held by grantor retained annuity trusts for the benefit of the reporting person's spouse and their two children, of which the reporting person's spouse is trustee and sole annuitant.
- F2The price reported is the weighted average of the shares sold. The shares were sold at varying prices in the range of $55.31 to $57.52. The reporting person undertakes, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
- F3This amount reflects 4,197 shares transferred from indirect to direct ownership from a grantor retained annuity trust distribution on July 28, 2017.
- F4This amount reflects 4,197 shares transferred from a grantor retained annuity trust distribution on July 28, 2017.
- F5Shares held by Vicki Lee Sato, who is the reporting person's spouse.
- F6The price reported is the weighted average of the shares sold. The shares were sold at varying prices in the range of $55.33 to $57.52. The reporting person undertakes, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
- F7The price reported is the weighted average of the shares sold. The shares were sold at varying prices in the range of $56.77 to $57.34. The reporting person undertakes, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
- F8The price reported is the weighted average of the shares sold. The shares were sold at varying prices in the range of $56.77 to $57.33. The reporting person undertakes, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
- F9Shares held by grantor retained annuity trusts for the benefit of the reporting person and his two children, of which the reporting person is trustee and sole annuitant.